• Crinetics Pharmaceuticals average return on tangible equity for 2023 was -55.89, a 21.84% decline from 2022.
• Crinetics Pharmaceuticals average return on tangible equity for 2022 was -45.87, a 8.22% increase from 2021.
• Crinetics Pharmaceuticals average return on tangible equity for 2021 was -49.98, a 12.42% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.